Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Oct. 31, 2022		979,869
Balance at beginning of period at Oct. 31, 2022	$ (3,025)	$ 10	$ 1,172	$ (4,492)	$ 285
Increase (Decrease) in Stockholders' Equity
Net earnings	469			469
Other comprehensive loss, net of taxes	(741)				(741)
Comprehensive income (loss)	(272)
Issuance of common stock in connection with employee stock plans and other (in shares)		8,844
Issuance of common stock in connection with employee stock plans and other	$ (79)		(79)
Repurchases of common stock (in shares)	(3,600)	(3,624)
Repurchases of common stock (Note 10)	$ (100)		(4)	(96)
Cash dividends	(518)			(518)
Stock-based compensation expense	167		167
Balance (in shares) at Jan. 31, 2023		985,089
Balance at end of period at Jan. 31, 2023	$ (3,827)	$ 10	1,256	(4,637)	(456)
Balance (in shares) at Oct. 31, 2023	989,000	988,782
Balance at beginning of period at Oct. 31, 2023	$ (1,069)	$ 10	1,505	(2,361)	(223)
Increase (Decrease) in Stockholders' Equity
Net earnings	622			622
Other comprehensive loss, net of taxes	(235)				(235)
Comprehensive income (loss)	387
Issuance of common stock in connection with employee stock plans and other (in shares)		8,677
Issuance of common stock in connection with employee stock plans and other	$ (76)		(76)
Repurchases of common stock (in shares)	(17,100)	(17,062)
Repurchases of common stock (Note 10)	$ (514)		(27)	(487)
Cash dividends	(545)			(545)
Stock-based compensation expense	$ 177		177
Balance (in shares) at Jan. 31, 2024	980,000	980,397
Balance at end of period at Jan. 31, 2024	$ (1,640)	$ 10	$ 1,579	$ (2,771)	$ (458)